This website is intended for journalists outside the US/UK, who are interested in media information from Boehringer Ingelheim.

Top Stories

 

  •  

    ASCO 2014: Giotrif® (afatinib) analysis presented

  •  

    ASCO 2014: New data presented

    Events and Initiatives

    ASCO 2014

    30 May - 3 June 2014
    ASCO 2014: Boehringer Ingelheim to present latest oncology research, including overall survival results for Giotrif® (afatinib) in advanced NSCLC

    Education Hub

     

    VIDEO

    Professor James Chih-Hsin Yang
    Lux-Lung 3 and Lux-Lung 6 :
    study design

     

    INFOGRAPHIC

    Nintedanib* Lume-Lung
    1 Clinical Trial

    INFOGRAPHIC

    Afatinib* Lux-Lung 3 & 6
    Clinical Trials

    Tweets from @Boehringer